Patricia K. Donahoe

Co-Founder & Advisor at Oviva Therapeutics

Patricia K. Donahoe is Director Pediatric Surgical Research Laboratories, Chief Emerita Pediatric Surgical Services MGH, and Marshall K. Bartlett Professor of Surgery Harvard Medical School. Her research focuses on Müllerian Inhibiting Substance in reproductive development and as a potential therapeutic for ovarian cancers, and recently, with David Pepin PhD, as an agent to enhance fertility, contraception and ovarian protection. An Associate Member of the Broad Institute and Faculty of the Harvard Stem Cell Institute and the Center for Human Genomic Research at MGH, Dr. Donahoe has trained >100 fellows and published >300 peer-reviewed articles. She is a member of the National Academy of Sciences (1999), National Academy of Medicine (1991), National Academy of Inventors (2021), and the American Academy of Arts & Sciences (1987).